LifeView

Interested in our tests? Click below to find IVF Centers currently offering our innovative testing.

ⓖ-PGTAcomparison-Bifold

September 1, 2020

What makes LifeView Better?

Backed by rigorous preclinical validation and a unique interdisciplinary approach that combines years of experience in molecular genetics and computational biology, LifeView provides a one-of-a-kind machine learning based prediction of genetic abnormalities. See more with greater confidence using LifeView PGT.

ⓖ-PGTA-Bifold

October 14, 2020

PGT-A

NGS uses copy number data that can lead to inaccurate diagnoses (particularly mosaicism) due to the inability to distinguish signal from noise. By combining copy number and genotyping data, LifeView provides the most accurate and highest resolution prediction of chromosomal abnormalities in the industry. Fewer false positives means more embryos available for transfer.

ⓖ-PGTSR-Bifold

November 28, 2020

PGT-SR

LifeView PGT-SR provides more than 5 times the resolution of NGS based testing and the ability to distinguish between balanced translocation carrier and truly normal embryos for our patients.

ⓖ-PGTM-Bifold

November 26, 2020

PGT-M

Rapid workups and broader accommodation of difficult cases means faster time to pregnancy for prospective patients. By combining linkage-based analysis of several hundred markers with direct testing of the mutation, LifeView PGT-M provides the most convenient, cost effective, and accurate method available.

ⓖ-PGTP-Bifold

November 26, 2020

PGT-P

The Embryo Health Score provides a unique opportunity for patients to rank euploid embryos to reduce the risk of several polygenic disorders. Importantly, the benefit of relative risk reduction is apparent even when only 2 euploid embryos are available for selection from a couple with no known family history of polygenic disease.

ⓖ-M2-Bifold

September 3, 2020

M2

Carriers of the M2 Haplotype can be identified using LifeView for M2. Carriers have a higher risk of several pregnancy complications and may benefit from low molecular heparin or LifeView PGT-M for M2 to improve the chance of reaching term delivery.